Literature DB >> 6106109

Should anti-D immunoglobulin be given antenatally?

G H Tovey.   

Abstract

A survey of 246 Rh-negative expectant mothers who had Rh antibodies for the first time has shown that in about 50% sensitisation might have been prevented had anti-D immunoglobulin (Ig) been injected after delivery of the previous Rh-positive baby. Sensitisation of the other mothers could have been prevented only by giving anti-D Ig antenatally during pregnancy. Perinatal mortality and morbidity in Britain from Rh-haemolytic disease in first-affected babies is now so low that an attempt to eliminate Rh-haemolytic disease by giving anti-D Ig to all expectant Rh-negative mothers during the antenatal period is not cost effective. If all Rh-negative mothers who abort or give birth to an Rh-positive baby are injected with an adequate dose of anti-D Ig within 72 h of delivery, the small number of mothers in whom measures to prevent sensitisation have failed can be reduced by 50%.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106109     DOI: 10.1016/s0140-6736(80)91898-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Obstetrics and gynecology: rh immune globulin update.

Authors:  E R Jennings
Journal:  West J Med       Date:  1986-01

2.  Rh(D) haemolytic disease of the newborn: the changing scene.

Authors:  S J Urbaniak
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

3.  Comparative risks of rhesus autoimmunisation in two different methods of mid-trimester abortion.

Authors:  C Brewer; E W Ball; R Beard; P Gittins
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

4.  Prevention of haemolytic diseases of the newborn due to anti-D.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-28

5.  Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.

Authors:  J G Thornton; C Page; G Foote; G R Arthur; L A Tovey; J S Scott
Journal:  BMJ       Date:  1989-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.